Scienmag

JUNE 18, 2021

The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, […].

Engineer 98

Engineer Scientist Development Research 98

Medical Xpress

APRIL 17, 2023

A KAIST research team led by Professor Keon Jae Lee from the Department of Materials Science and Engineering and the College of Medicine of the Catholic University of Korea has developed a highly sensitive, wearable piezoelectric blood pressure sensor.

Engineer 84

Engineer Medicine Development Research 84

Scienmag

JULY 19, 2021

Part of […].

Engineer 75

Engineer Development Cardiology Medicine 75

Scienmag

MARCH 19, 2021

Scientists at The Ohio State University Wexner Medical Center, College of Engineering and College of Medicine have developed technology to “retrain” cells to help repair damaged brain tissue.

Scientist 57

Scientist Engineer Medicine Development 57

pharmaphorum

OCTOBER 2, 2020

He has used innovative and collaborative strategies to develop and refine a multi-modality ‘recruitment engine’ and led one of the UK’s first ‘virtual’ interventional trials. His main interest is in improving access to clinical trials through community-based participation, consent for contact registries and a digital media platform.

Clinical Trials 92

Clinical Trials Clinical Trials Clinical Research Life Science 92

Delveinsight

JULY 22, 2021

The decision gave Bayer complete control of BlueRock’s cell therapy pipeline, headed by DA01 and spanning various diseases in the neurology , cardiology , and immunology categories. Omniscient Neurotechnology rakes in USD 29 Million to map out the electrical networks.

Cardiology 98

Cardiology Development Engineer Clinical Trials 98

Delveinsight

AUGUST 4, 2020

MorphoSys in-licensed Monjuvi, which is a humanized Fc-engineered monoclonal antibody against CD19 – the same protein which CAR-T cell therapies target and is in abundance in cancerous B cells, from Xencor in 2010 and is under evaluation in B-cell malignancies in several ongoing combination trials.

Cardiology 55

Cardiology Antibody FDA Approval Trials 55

The Pharma Data

MAY 31, 2022

About BlueRock Therapeutics BlueRock Therapeutics is a leading engineered cell therapy company with a mission to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition.

Trials 52

Trials Engineer Clinical Trials Clinical Trials 52

pharmaphorum

OCTOBER 2, 2020

He has used innovative and collaborative strategies to develop and refine a multi-modality ‘recruitment engine’ and led one of the UK’s first ‘virtual’ interventional trials. His main interest is in improving access to clinical trials through community-based participation, consent for contact registries and a digital media platform.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Life Science 52

The Pharma Data

OCTOBER 25, 2020

The integrated pump lung unit is engineered with volute spiral technology for uniform blood flow with minimal stagnation and advanced gas exchange technology that allows for full therapy with reduced oxygen requirements. This benefit is not seen in patients treated with ECMO combined with the intra-aortic balloon pump (IABP). (

Cardiology 52

Cardiology FDA Approval Development Engineer 52

Scienmag

MARCH 9, 2021

Credit: Mark Stone/University of Washington Smart speakers, such as Amazon Echo and Google Home, have proven adept at monitoring certain health care issues at home. For example, researchers at the University of Washington have shown that these devices can detect cardiac arrests or monitor babies breathing.

Research 96

Research Cardiology Engineer Medicine 96

XTalks

JULY 10, 2023

We did not get a Class II certification for diabetes only, or orthopedics or cardiology; we got a disease-agnostic certification. Now, as we develop new predictive algorithms, whether that is in diabetes, cardiology, respiratory or oncology, we can bring those algorithms to our platform because it is disease-agnostic.

Life Science 52

Life Science Cardiology Regulation Pharma Companies 52

Scienmag

APRIL 22, 2021

Credit: Kobe University Kobe University Hospital’s Dr. NISHIMORI Makoto and Project Assistant Professor KIUCHI Kunihiko et al. (of

Development 85

Development Medicine Cardiology Engineer 85

Scienmag

NOVEMBER 3, 2020

Researchers report rubbery bioelectronic cardiac patch Credit: University of Houston Pacemakers and other implantable cardiac devices used to monitor and treat arrhythmias and other heart problems have generally had one of two drawbacks – they are made with rigid materials that can’t move to accommodate a beating heart, or they are made (..)

Research 80

Research Cardiology Engineer Medicine 80

Scienmag

MAY 10, 2021

Stimulators win top award at circuitry conference, could aid spinal cord, heart therapies Credit: Secure and Intelligent Micro-Systems Lab/Rice University HOUSTON – (May 10, 2021) – Implants that require a steady source of power but don’t need wires are an idea whose time has come.

Cardiology 63

Cardiology Engineer Medicine 63

Scienmag

OCTOBER 26, 2020

Dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy Credit: Khademhosseini Laboratory (LOS ANGELES) – Breast cancer is the most commonly occurring cancer for women around the world, and much effort has been spent in the development of therapies to treat this disease.

Development 58

Development Cardiology Engineer Research 58

Scienmag

SEPTEMBER 7, 2020

A new class of medical instruments equipped with a soft electronics system improves diagnostic and therapeutic interventions in minimally invasive surgeries Credit: John Rogers/Northwestern University SUMMARY Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that could dramatically improve the (..)

Development 52

Development Research Cardiology Engineer 52

Scienmag

OCTOBER 14, 2020

Researchers unravel the healing mechanisms of extracellular vesicles and demonstrate their healing power on a heart-on-a-chip Credit: (Image courtesy of the Disease Biophysics Group/Harvard SEAS) Extracellular vesicles (EVs) — nanometer sized messengers that travel between cells to deliver cues and cargo — are promising tools for the next (..)

Research 52

Research Cardiology Engineer Medicine 52

Scienmag

JANUARY 25, 2021

A twist on the decade’s-old design improves blood flow, prevents clots Credit: UBCO New research coming out of UBC’s Okanagan campus may take the current ‘gold standard’ for heart valves to a new level of reliability.

Research 58

Research Development Cardiology Engineer 58

Scienmag

MAY 14, 2021

Multi-institutional team combined expertise to make discovery Credit: University of Missouri Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long (..)

Drugs 53

Drugs Cardiology Engineer Medicine 53

Scienmag

APRIL 28, 2021

For the first time, researchers have identified the specific mechanism of von Willebrand Factor (vWF) — an essential blood clotting protein — that enables it to bind to platelets and initiate clotting Under normal, healthy circulatory conditions, the von Willebrand Factor (vWF) keeps to itself.

Scientist 53

Scientist Protein Drugs Research 53

Scienmag

NOVEMBER 9, 2020

Credit: Penn State UNIVERSITY PARK, Pa. — Sensors that monitor a patient’s condition during and after medical procedures can be expensive, uncomfortable and even dangerous.

Research 52

Research Cardiology Engineer Medicine 52

Scienmag

DECEMBER 22, 2020

Credit: Khademhosseini Lab (LOS ANGELES) – There are many different events which may lead to excessive and uncontrolled bleeding within the body. This can occur as a result of inflammation and ulcerations, abnormalities in the blood vessels or trauma-related injuries.

Cardiology 52

Cardiology Engineer Medicine 52

Scienmag

MAY 18, 2021

Lehigh University researchers’ breakthrough could advance diagnosis and treatment of bleeding disorder and lead to improved design of left ventricular assist devices used in heart failure patients For the first time, researchers can quantitatively predict blood flow conditions that likely cause pathological behavior of the human blood protein (..)

Protein 43

Protein Research Cardiology Engineer 43

Scienmag

NOVEMBER 6, 2020

It’s time to act In a current opinion article “Reduction of environmental pollutants for prevention of cardiovascular disease: it’s time to act”, published in the European Heart Journal this week, a group of international environmental researchers from the University Medical Center of Mainz (Thomas Münzel and Andreas Daiber), (..)

Research 44

Research Cardiology Engineer Medicine 44

Scienmag

FEBRUARY 24, 2021

A new microchip could help scientists uncover secrets of heart regeneration in baby mice Baby mice might be small, but they’re tough, too. For their first seven days of life, they have the special ability to regenerate damaged heart tissue. Humans, on the other hand, aren’t so lucky: any heart injuries we suffer could lead […].

Scientist 40

Scientist Cardiology Engineer Medicine 40

Scienmag

OCTOBER 26, 2020

RIT researchers receive funding for innovative project to improve health and quality of life for the aging population A research team at Rochester Institute of Technology recently won a Catalyst Award from the National Academy of Medicine for their project, “Improving Health for the Aging through Daily Vital Signs Monitoring.”

Research 40

Research Medicine Cardiology Engineer 40

Scienmag

SEPTEMBER 29, 2020

In a proof-of-concept study, North Carolina State University researchers reported promising preclinical findings for a prototype of a vascular graft designed as a replacement for a damaged or blocked coronary artery, which supplies blood to the heart.

Research 40

Research Cardiology Engineer Medicine 40

Scienmag

DECEMBER 3, 2020

FAIRFAX, Va.–

Cardiology 40

Cardiology Engineer Medicine 40

Eye on FDA

MARCH 26, 2021

In May the American College of Cardiology will be holding their annual meeting – ACC.21. But it is time to start thinking about how we engineer the return journey. But it becomes painfully obvious that it is not a substitute for the real thing.

Vaccine 96

Vaccine Vaccination Cardiology Gene Therapy 96

pharmaphorum

APRIL 12, 2021

Lead investigator Mikhail Kosiborod of Saint Luke’s said that while the result was disappointing “the findings are very interesting and valuable, and will inform future clinical science” The data will be presented in full next month at the American College of Cardiology (ACC) congress.

Cardiology 86

Cardiology Antibody Trials Drugs 86

The Pharma Data

SEPTEMBER 15, 2020

With the depth and breadth of our current portfolio, the tremendous potential of our pipeline and scientific engine, and the power of our culture of innovation, we are poised to continue delivering meaningful value to patients by addressing some of the world’s most difficult health challenges.”. and -50.4%

Gene Therapy 52

Gene Therapy Vaccine Vaccination Trials 52

The Pharma Data

MAY 13, 2021

Journal of the American College of Cardiology. Journal of Food Engineering. DOI: 10.1111/adb.12134. Malik VS, Hu FB. Fructose and Cardiometabolic Health: What the Evidence from Sugar-Sweetened Beverages Tells Us. 2015;66(14):1615-1624. DOI: 10.1016/j.jacc.2015.08.025. 2015.08.025. . Mason AE, Epel ES, Aschbacher K, et al.

Insulin 52

Insulin Production Hormones Medicine 52

XTalks

OCTOBER 25, 2024

Additionally, its compact design and advanced engineering allow for quieter and more efficient performance, making it a more comfortable and reliable option for patients. Our hope is that the TEAM-HF study will revolutionize care management for these patients and their families.

Trials 105

Trials Manufacturing FDA Approval Marketing 105